
Selank is a Russian-synthesized heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) based on the immunoregulatory tetrapeptide tuftsin, with stabilizing proline residues added to extend its biological half-life. It has been characterized in Russian neuropeptide and immunology literature.
Published research describes Selank modulating GABAergic neurotransmission, increasing BDNF expression, and influencing enkephalin-related pathways. Studies also note immune modulation effects on cytokine balance.
Developed at the same Moscow-based institute as Semax. Used in Russian clinical practice for anxiety research but not approved in the US or EU.
Published research literature covers the following areas:
LAR supplies this compound as a reference standard to qualified laboratories. No dosing schedules, administration methods, or human-use guidance is provided or implied.
Sealed vial: Stable at refrigerated temperatures (2–8 °C) for up to 24 months. Stable at room temperature (up to 25 °C) for 30 days during shipping.
After opening: Refrigerate at 2–8 °C and use within 30 days. Protect from light. Do not freeze after opening.
Visual check: Solution should remain clear. Discard if discoloration or precipitate appears.
Every batch is independently tested for purity, mass, and endotoxin load. Click any report to view the full analysis.
No. Research peptides supplied by LAR are reference materials for laboratory investigation. They are not approved by the FDA or any national regulatory body for human use.
Yes. Vials ship as lyophilized powder, giving your lab control over solvent selection and final concentration. Reconstitution should follow your laboratory's standard practice.
Each manufacturing batch is tested by an independent third-party laboratory using HPLC-UV analysis. The full report, including chromatogram and mass spectrometry, is available above.
Orders ship within 1–2 business days via discreet packaging.